biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Denali & Bioasis why not

<< Previous

Bullboard Posts

Next >>

Comment by OysterBuctoucheon Jul 28, 2021 7:59am

115 Views

Post# 33615457

RE:Denali & Bioasis why not

Good discussion IT. And if i read you right you are not saying this is a need to be for BTI -but rather hanging it out there and saying BTI is likely on the Denali radar. And at low share price and investor fatigue at an all time high -the risk/reward for a cheap take out is real. More reason why timing is important for another deal or two with revenue. Market is saying show me the money. And so are the shareholders. And without it we could be taken out cheap.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario